Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081

NCT04608955 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: WX-081
DRUG: Bedaquiline
DRUG: Standard treatment
DRUG: Multi-drug background treatment (MBT)

Sponsor

Shanghai Jiatan Pharmatech Co., Ltd